Evidence map›Paper›PMID 42626760›Full record

ArticleTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie2026

The Current State of in vitro Diagnostics Evaluation in Sub-Saharan African Countries: Insights from the Advanced Workshop.

Jens Reinhardt, Chancelar Kafere, Albert Maqolo, Goran Abdurrahman, Emmanuel Willie, Aggrey Phiri, Kapunda Masuwa, Frank Laban, Abhimanyu Shivhare, Ivan Emil Mwikarago and 9 more

Abstract read
In one paragraph

Article in Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Jens ReinhardtPaul-Ehrlich-Institut, Langen, Germany.
Chancelar KaferePaul-Ehrlich-Institut, Langen, Germany.
Albert MaqoloPaul-Ehrlich-Institut, Langen, Germany.
Goran AbdurrahmanTÜV Rheinland, Köln, Germany.
Emmanuel WillieLiberia Medicines and Health Products Regulatory Authority (LMHRA), Monrovia, Liberia.
Aggrey PhiriWorld Health Organization - Malawi Country Office, Lilongwe, Malawi.
Kapunda MasuwaZambia Medicines Regulatory Authority (ZAMRA), Lusaka, Zambia.
Frank LabanZambia Medicines Regulatory Authority (ZAMRA), Lusaka, Zambia.
Abhimanyu ShivhareRwanda Food and Drug Authority (RFDA), Kigali, Rwanda.
Ivan Emil MwikaragoRwanda Food and Drug Authority (RFDA), Kigali, Rwanda.
Khanyisile Zachia NkukuSouth African Health Product Regulatory Authority (SAHPRA), Pretoria, South Africa.
Erick KitangalaPharmacy and Poisons Board (PPB), Nairobi, Kenya.
Hafiza MogesEthiopian Food and Drug Authority (EFDA), Addis Ababa, Ethiopia.
Edina ZebedayoTanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania.
Joseph Donkor IssacharGhana Food and Drug Authority (FDA), Accra, Ghana.
Linda NhukarumeMedicines Control Authority of Zimbabwe (MCAZ), Harare, Zimbabwe.
Arinzechukwu IkemefunaNational Agency for Food and Drug Administration and Control (NAFDAC), Abuja, Nigeria.
Saren ShifotokaMinistry of Health and Social Services (MoHSS), Windhoek, Namibia.
Lilian MutesiNational Drug Authority (NDA), Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Although the African Union Development Agency-New Partnership for Africa's Development (AUDA-NEPAD) has initiated activities to support the establishment of a harmonized regulatory framework for in vitro diagnostics (IVDs), including those for testing blood and blood components, challenges such as limited infrastructure and insufficient technical expertise remain. The Global Health Protection Programme (GHPP) project BloodTrain, which seeks to strengthen regulatory systems for blood and blood products in Africa, addressed this by organizing an advanced workshop focused on IVD technical assessment. Data on national IVD regulatory systems were also collected through a structured questionnaire. Furthermore, a survey was conducted to evaluate both the perceived usefulness of the training and the applicability of the tools provided. Methods: An advanced training was conducted for personnel from 14 African national regulatory authorities who possessed prior knowledge and experience in the assessment of IVDs. The participants were also granted access to online courses on IVD technical file assessment. The workshop comprised theory and case study exercises by experts from TÜV Rheinland and BloodTrain, complemented by presentations from the participants on their national IVD regulatory systems. These presentations led to the development of a questionnaire to achieve a comparison of these regulatory systems. Results: In the survey, the workshop content resulted in a mean score of 4.5 on a 5-point scale. Lesser mean scores on workshop duration and previous knowledge to follow the workshop underline the need for additional training on IVD assessment. The comparative assessment of the regulatory criteria for IVDs collected by a post-workshop questionnaire showed the majority of the participating countries already had some level of regulation on IVDs, but there are still gaps that need to be addressed. Conclusion: The advanced IVD workshop provided well-appreciated training on IVD dossier assessment and also delivered understanding of the heterogenous regulatory landscape in the participating countries. While the questionnaire suggested that in most of the participating countries regulatory systems for IVDs are already in use, the survey painted a differentiated picture with heterogenous preexisting knowledge and the expectation that the trained content will be helpful in the future.

Indexed as

Advanced training workshop: sub-Sahara AfricaBlood safetyBloodTrainIn vitro diagnostics assessment

Identifiers

PMID42626760
PMCPMC13493129

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.